Kite Pharma is the Global University Venturing 2013 Investment of the Year.
Of all the different types of university research to be commercialised, biotechnology is perhaps the most difficult. There are multiple pitfalls, including high failure rates, drugs being blocked by regulators and management clashes that can cause a company to stagnate Any of these may scupper biotech as it is translated from labs to reality. But…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
